Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study
Saved in:
| Published in: | Open Forum Infectious Diseases |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study
- Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
- Combined Cryptococcal and Bacterial Meningitis in an Immunocompetent 15-Year-Old: A Case Report
- Isoniazid Preventive Therapy Adherence and Associated Factors among HIV Positive Patients in Addis Ababa, Ethiopia
- Efficacy and safety of drug therapies for treating tuberculous meningitis: a network meta-analysis
- Cryptococcal Osteomyelitis in a Virally Suppressed Adolescent Living With HIV: A Case Report
- Cryptococcal Lung Infection Simulating Metastasis in a Myxoid Liposarcoma Patient: A Case Report